Merck KGaA Company Profile (FRA:MRK)

About Merck KGaA

Merck KGaA logo.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: FRA
  • Symbol: MRK
  • CUSIP:
Key Metrics:
  • Previous Close: $102.95
  • 50 Day Moving Average: $102.024
  • 200 Day Moving Average: $97.604
  • Trailing P/E Ratio: 30.176
  • P/E Growth: 1.490
  • Market Cap: $44.90B
Additional Links:
Companies Related to Merck KGaA:

Analyst Ratings

Consensus Ratings for Merck KGaA (FRA:MRK) (?)
Ratings Breakdown: 12 Hold Ratings, 9 Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: €104.85

Analysts' Ratings History for Merck KGaA (FRA:MRK)
DateFirmActionRatingPrice TargetDetails
2/22/2017Warburg ResearchSet Price TargetBuy€110.00View Rating Details
2/21/2017Morgan StanleySet Price TargetNeutral€103.00View Rating Details
2/20/2017Deutsche Bank AGSet Price TargetBuy€118.00View Rating Details
2/8/2017Commerzbank AgSet Price TargetNeutral€109.00View Rating Details
2/7/2017DZ Bank AGReiterated RatingBuyView Rating Details
2/7/2017J P Morgan Chase & CoReiterated RatingNeutralView Rating Details
1/24/2017Goldman Sachs Group, Inc. (The)Set Price TargetNeutral€105.00View Rating Details
1/12/2017Citigroup Inc.Set Price TargetBuy€116.00View Rating Details
12/9/2016Berenberg BankSet Price TargetNeutral€101.00View Rating Details
11/30/2016Bank of America CorpSet Price TargetBuy€115.00View Rating Details
11/17/2016BNP ParibasSet Price TargetBuy€114.00View Rating Details
11/17/2016HSBC Holdings plcSet Price TargetNeutral€95.00View Rating Details
11/16/2016Societe GeneraleSet Price TargetNeutral€97.00View Rating Details
11/15/2016Independent Research GmbHSet Price TargetNeutral€102.00View Rating Details
11/15/2016Bankhaus LampeSet Price TargetBuy€112.00View Rating Details
11/15/2016Nord/LBSet Price TargetBuy€114.00View Rating Details
11/15/2016equinet AGSet Price TargetNeutral€91.00View Rating Details
11/15/2016S&P Global Inc.Set Price TargetNeutral€103.00View Rating Details
8/5/2016Credit Suisse GroupSet Price TargetBuy€108.00View Rating Details
8/5/2016Baader BankSet Price TargetNeutral€97.00View Rating Details
5/10/2016Barclays PLCSet Price TargetNeutral€87.00View Rating Details
12/11/2015S&P Equity ResearchSet Price TargetNeutral€104.00View Rating Details
12/7/2015Kepler Capital MarketsSet Price TargetSell€75.00View Rating Details
(Data available from 2/25/2015 forward)


Earnings History for Merck KGaA (FRA:MRK)
No earnings announcements for this company have been tracked by


Earnings Estimates for Merck KGaA (FRA:MRK)
No earnings estimates for this company have been tracked by


Dividend History for Merck KGaA (FRA:MRK)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Merck KGaA (FRA:MRK)
No insider trades for this company have been tracked by


Latest Headlines for Merck KGaA (FRA:MRK)
News IconNo problem, Houston (FRA:MRK) - February 24 at 9:02 PM
News IconCSX cutting 1000 management jobs; most are in Jacksonville (FRA:MRK) - February 24 at 4:01 PM logoIs Pfizer's Research Pipeline Truly Undervalued? (FRA:MRK) - February 24 at 4:01 PM
News IconCast aside by Merck KGaA, new MS drug shows promise - The Pharma Letter (registration) (FRA:MRK) - February 22 at 8:33 AM logoMerck & Co., Inc. (MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact (FRA:MRK) - January 30 at 9:38 AM
News IconPrivate Harbour Investment Management & Counsel LLC Reduces Stake in Merck & Co. (MRK) (FRA:MRK) - January 27 at 3:20 AM
News IconMerck and Genea open 'Center of Excellence' for fertility treatments - The Pharma Letter (registration) (FRA:MRK) - January 22 at 11:29 PM logoAsco-GI: Opdivo Heads Close Pack Of Anti-PD-1s In Gastric Cancer (FRA:MRK) - January 20 at 7:26 PM
News IconMerck & Company, Inc. (NYSE:MRK) Broker Price Targets For The Coming Week (FRA:MRK) - January 20 at 7:26 PM
News IconThe Commerzbank AG Analysts Give Merck KGaA (MRK) a €101.00 Price Target (FRA:MRK) - January 12 at 7:12 PM
News IconFinancial Advisory Group Exits Position in Merck & Co. (MRK) (FRA:MRK) - January 12 at 7:12 PM
News IconMerck KGaA (MRK) Given a €116.00 Price Target at Citigroup Inc (FRA:MRK) - January 12 at 7:12 PM
News IconMerck KGaA (MRK) Given a €101.00 Price Target at Commerzbank AG (FRA:MRK) - January 12 at 7:12 PM logoMerck KGaA, Vertex Announce Tie-Up for Oncology Programs (FRA:MRK) - January 12 at 7:12 PM logoGermany’s Merck Taps Palantir for Big Data Health Initiative (FRA:MRK) - January 12 at 7:12 PM
News IconMerck & Co., Inc. (NYSE:MRK) (FRA:MRK) - January 11 at 7:15 PM
News IconMerck & Company, Inc. (MRK) Position Increased by the Trust Co (FRA:MRK) - January 11 at 7:15 PM
News Icon(NYSE:MRK) is working with Moffitt Cancer Center (FRA:MRK) - January 11 at 7:15 PM
News IconInnovative access to medicines strategies in lower income countries - The Pharma Letter (registration) (FRA:MRK) - January 11 at 12:32 AM logoMerck KGaA CEO: Drug Pricing Debate Is ‘Natural’ (FRA:MRK) - January 10 at 7:31 PM
News Icon(NYSE:MRK) Insider Ownership stands at 0.04 (FRA:MRK) - January 7 at 5:25 AM
News IconAcadian Asset Management LLC Has $16342000 Stake in Merck & Company, Inc. (MRK) (FRA:MRK) - January 7 at 5:25 AM
News IconMerck KGaA MRK Medical Equipment Deals and Alliances Profile Prices from USD $250 (FRA:MRK) - January 7 at 5:25 AM logoMerck : approves appointment of Director (FRA:MRK) - December 26 at 10:04 AM
News IconMerck KGaA (MRK) Receives €103.34 Average Price Target from Brokerages (FRA:MRK) - December 21 at 10:02 AM
News IconMerck & Co. (MRK) is Downgraded by Jefferies to Underperform (FRA:MRK) - December 20 at 12:33 PM
News IconQ4 2016 EPS Estimates for Merck & Co. (MRK) Decreased by Analyst (FRA:MRK) - December 20 at 12:33 PM logoAvelumab: The First US Treatment for Metastatic Skin Cancer? (FRA:MRK) - December 9 at 6:39 PM
News IconMerck KGaA MRK Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (FRA:MRK) - December 5 at 10:15 AM logoThis Small-Cap Biotech Is Tapping A $200 Billion Market (FRA:MRK) - December 3 at 11:15 AM
News IconStock Watch: Focusing in on Merck KGaA (DB:MRK) - The Business Journal (FRA:MRK) - December 2 at 6:21 PM logoPharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda (FRA:MRK) - December 2 at 10:17 AM logoGerman Merck, Pfizer get FDA priority review for cancer drug (FRA:MRK) - November 29 at 2:47 PM
News IconSheriff: 3 dead in Compton shooting; no word about suspects (FRA:MRK) - November 25 at 11:31 AM
News IconBNP Paribas Analysts Give Merck KGaA (MRK) a €114.00 Price Target (FRA:MRK) - November 25 at 11:31 AM logoMerck KGaA's (MKGAF) Q3 Earnings and Sales Increase Y/Y (FRA:MRK) - November 16 at 9:56 AM logoMerck KGaA net income rises 25.5% (FRA:MRK) - November 15 at 6:52 PM
News IconMerck Raises Guidance (FRA:MRK) - November 15 at 9:55 AM
News IconPfizer lines up three experimental I/O meds for NCI research tie-up (FRA:MRK) - November 14 at 10:23 AM
News IconMerck KGaA 3Q 2016 -- Forecast (FRA:MRK) - November 11 at 5:59 PM logo3 Things To Watch When Mylan Reports Earnings On Wednesday (FRA:MRK) - November 8 at 5:53 PM logo“Merck More than a Mother” addresses infertility challenges and solutions in Africa in partnership with IFFS (FRA:MRK) - November 4 at 9:41 AM
News Icon(NYSE:MRK) Reported 0.93 EPS in the last quarter (FRA:MRK) - October 23 at 10:32 AM
News IconMerck KGaA expands biologics site that produces hot-selling Gonal-f (FRA:MRK) - October 18 at 11:33 AM logoPeregrine Pharmaceuticals - A Misunderstood And Undervalued Biotech With Significant Upside Potential (FRA:MRK) - October 17 at 6:09 PM logoPharma Stock Roundup: Mylan in EpiPen Medicaid Settlement, ESMO Data in Focus (FRA:MRK) - October 14 at 9:32 AM logoMerck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile - New Market Report (FRA:MRK) - October 13 at 6:19 PM
News IconGerman Merck, Vaccinex ink lung cancer anti-PD-L1 combo trial deal (FRA:MRK) - October 8 at 5:50 PM logoGermany stocks mixed at close of trade; DAX up 0.19% (FRA:MRK) - September 22 at 11:02 AM logoEU court says Lundbeck pay-for-delay deals anti-competitive (FRA:MRK) - September 9 at 10:55 AM


What is Merck KGaA's stock symbol?

Merck KGaA trades on the FRA under the ticker symbol "MRK."

Where is Merck KGaA's stock going? Where will Merck KGaA's stock price be in 2017?

21 equities research analysts have issued twelve-month price objectives for Merck KGaA's shares. Their predictions range from €87.00 to €118.00. On average, they anticipate Merck KGaA's share price to reach €104.85 in the next year.

Last Updated on 2/25/2017 by Staff